-Pamela A. Simonton Promoted to Executive Vice President and General
Counsel- -Gisela M. Schwab Promoted to Executive Vice President and Chief Medical
SOUTH SAN FRANCISCO, Calif., Jan. 4 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) today announced promotions for two members of its senior management team. Pamela A. Simonton, Senior Vice President of Patents and Licensing, has been promoted to Executive Vice President and General Counsel and Dr. Gisela M. Schwab, Senior Vice President and Chief Medical Officer, has been promoted to Executive Vice President and Chief Medical Officer.
"I am happy to promote both Pamela and Gisela. Both have played key roles in Exelixis' accomplishments, and both promotions are well-deserved. Pamela will now have responsibility for all corporate legal matters and legal services in support of Exelixis' business and corporate objectives," said George Scangos, Ph.D., President and Chief Executive Officer of Exelixis. "Pamela has been responsible for all of the patent and licensing activity since her arrival in 2000 and has played a major role in our partnering activities as well. Dr. Schwab will continue to lead the Development Organization as we plan to move 3 compounds into pivotal trials in the first half of 2008."
Ms. Simonton has served as Senior Vice President, Patents and
Licensing, since January 2004. Previously, she served as Vice President of
Corporate Technology Development from April 2000 through December 2003.
From July 1996 to April 2000, she served as Vice President, Licensing and
Acquisitions for Bayer Corporation's Pharmaceutical Division. From
September 1994 to July 1996, Ms. Simont
|SOURCE Exelixis, Inc.|
Copyright©2008 PR Newswire.
All rights reserved